DWM
ARNA

Doyle Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Doyle Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$12K – 824
2019
Q2 		$12K Buy
+200
New +$10.3K ﹤0.01% 606
2019
Q1 		– Sell
-200
Closed -$8K – 821
2018
Q4 		$8K Buy
+200
New +$7.85K ﹤0.01% 670

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Doyle Wealth Management's ARNA Position: Q3 2019 in Review

Doyle Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 200 shares — an estimated $12K sold.

Doyle Wealth Management first reported a position in ARNA in Q4 2018 and held it in 2 quarters. The position peaked at $12K in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

  • Doyle Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 200 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $12K.
  • Doyle Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 2 quarters.
  • Doyle Wealth Management's Arena Pharmaceuticals Inc position peaked at $12K in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.